Randomized Trial Archives - PsychPartners

How Naltrexone-Bupropion Treats Meth Use Disorder

Addiction Meds Depression Disorders Methamphetamine Research Substance Use

How Naltrexone-Bupropion Treats Meth Use Disorder

July 29, 2026by Chris Aiken, MD0

Oral Ozempic Delivers Mixed Results on Alcohol Use

Alcohol GLP1 Agonists Medications Research Substance Use

Oral Ozempic Delivers Mixed Results on Alcohol Use

July 29, 2026by Chris Aiken, MD0

Omega-3 Combo for Mild Cognitive Impairment

Cognition Depression Geriatric Psychiatry Research Research for the Public Supplements

Omega-3 Combo for Mild Cognitive Impairment

July 28, 2026by Chris Aiken, MD0

Memantine for Cognition in Bipolar: New Trial

Bipolar Cognition Disorders Research

Memantine for Cognition in Bipolar: New Trial

July 27, 2026by Chris Aiken, MD0

Ketamine for Addiction

Addiction Meds Alcohol Cocaine Disorders Ketamine Medications Opioids Research Substance Use

Ketamine for Addiction

July 24, 2026by Chris Aiken, MD0

Saffron for Sleep in Lung Disease

Disorders Med-Psych Research Research for the Public Sleep Supplements

Saffron for Sleep in Lung Disease

July 22, 2026by Chris Aiken, MD0

Fluoxetine: A Problematic Trial in Ages 4-6

Antidepressants Child Psychiatry Depression Disorders Medications Research

Fluoxetine: A Problematic Trial in Ages 4-6

July 16, 2026by Chris Aiken, MD0

Vortioxetine vs SSRI: Without Industry Funding

Antidepressants Depression Medications Research

Vortioxetine vs SSRI: Without Industry Funding

July 16, 2026by Chris Aiken, MD2

Fluoxetine to Prevent PTSD After a Trauma

Antidepressants Disorders Med-Psych Medications PTSD Research Research for the Public Top Research

Fluoxetine to Prevent PTSD After a Trauma

July 15, 2026by Chris Aiken, MD0

Is Two Weeks of iTBS Enough?

Depression Difficult to Treat Depression Neuromodulation/TMS Research

Is Two Weeks of iTBS Enough?

July 12, 2026by Chris Aiken, MD0

Lemborexant Passes Its First Cirrhosis Test

Disorders Hypnotics Med-Psych Medications Research Sleep

Lemborexant Passes Its First Cirrhosis Test

July 11, 2026by Chris Aiken, MD0

Ketamine and Cognition, A Randomized Trial

Cognition Depression Difficult to Treat Depression Ketamine Medications Research

Ketamine and Cognition, A Randomized Trial

July 10, 2026by Chris Aiken, MD0

A Biomarker for SSRI vs Bupropion

Antidepressants Depression Difficult to Treat Depression Disorders Medications Research

A Biomarker for SSRI vs Bupropion

July 9, 2026by Chris Aiken, MD0

Amphetamine vs. Methylphenidate in ADHD

ADHD Child Psychiatry Medications Research

Amphetamine vs. Methylphenidate in ADHD

July 8, 2026by Chris Aiken, MD0

Ultrasound: A New Neuromodulation for Depression

Depression Devices Disorders Neuromodulation/TMS Research

Ultrasound: A New Neuromodulation for Depression

July 7, 2026by Chris Aiken, MD0

Lumateperone Falls Short in Borderline

Antipsychotics Disorders Medications Personality Disorders Research

Lumateperone Falls Short in Borderline

July 5, 2026by Chris Aiken, MD0

Saffron Helps Mood and Self-Esteem in Older Women

Depression Disorders Geriatric Psychiatry Research Research for the Public Supplements Top Research Women's Health

Saffron Helps Mood and Self-Esteem in Older Women

July 5, 2026by Chris Aiken, MD0

AI Therapy for Anxiety: CBT vs Psychodynamic Chatbots

ADHD Anxiety Autism Disorders Research Therapy

AI Therapy for Anxiety: CBT vs Psychodynamic Chatbots

June 28, 2026by Chris Aiken, MD0

A Laxative That Sharpens Memory

Antidepressants Cognition Depression Difficult to Treat Depression Research Top Research

A Laxative That Sharpens Memory

June 27, 2026by Chris Aiken, MD0

Fiber Lifts Mood in Adults with Obesity

Med-Psych Nutrition Research Research for the Public Side Effects Supplements

Fiber Lifts Mood in Adults with Obesity

June 27, 2026by Chris Aiken, MD1